-
Ferring celebrated its 60th anniversary
in TIMELINES onFerring was founded in 1950 and celebrated its 60th anniversary in 2010. The company has evolved from a small 2-people…
0 -
Extension study with FIRMAGON® (degarelix) showed continued benefits for prostate cancer patients beyond one year
in PRESS RELEASE 2010 onData recently presented on FIRMAGON® (degarelix) hormonal therapy for prostate cancer showed that long-term use beyond one year…
-
Ferring acquires LYSTEDA™ from Xanodyne Pharmaceuticals, Inc.
in PRESS RELEASE 2010 onFerring Pharmaceuticals today announced an agreement that will expand its Women’s Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical’s LYSTEDA™…
-
Consider the “whole-man” when treating prostate cancer
in PRESS RELEASE 2010 onHealthcare professionals need to consider the impact of prostate cancer on the ‘whole man’ rather than focusing on cancer treatment in isolation, according to results from an international survey of prostate cancer patients and their partners…
-
Wake Up to Nocturia Studies Reinforce Serious Associated Risk of Nocturia
in PRESS RELEASE 2010 onStudy results discussed today at the European Association of Urology (EAU) Congress in Barcelona, have reinforced the association between nocturia and a greater risk of falls and mortality…
-
Xanodyne and Ferring announce co-promote for ZIPSOR™
in PRESS RELEASE 2010 onXanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women’s healthcare and pain management…
-
FIRMAGON® has a significantly greater probability of PSA recurrence-free survival than leuprolide in prostate cancer patients
in PRESS RELEASE 2009 onResults from a phase III pivotal study sub-analyses reported in European Urology show that…
-
Launch of FIRMAGON
in TIMELINES onLaunch of FIRMAGON® (degarelix), a GnRH blocker for advanced hormone-dependent prostate cancer.
-
Ferring donates $3 million to the Royal Textile Academy of Bhutan
in PRESS RELEASE 2009 onFrederik Paulsen, Chairman, Ferring Pharmaceuticals, announced a $3 million donation to the Royal Textile Academy of Bhutan…
-
Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2010 Theme Announced
in PRESS RELEASE 2009 onFerring Pharmaceuticals is proud to announce the second Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) today…
Author archive for pulse
Articles by: pulse
